These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7555597)

  • 1. The effect of non-enzymatic glycation on recombinant human aldose reductase.
    Yamaoka T; Oda A; Bannai C; Itakura M; Yamashita K
    Diabetes Res Clin Pract; 1995 Mar; 27(3):165-9. PubMed ID: 7555597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.
    Sugiyama K; Chen Z; Lee YS; Kador PF
    Biochem Pharmacol; 2000 Feb; 59(4):329-36. PubMed ID: 10644040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kidney aldose and aldehyde reductases.
    Sato S; Kador PF
    J Diabetes Complications; 1993; 7(3):179-87. PubMed ID: 8343612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S; Sugiyama K; Carper D
    Adv Exp Med Biol; 1997; 414():499-505. PubMed ID: 9059655
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldose reductase inhibitors as pathobiochemical probes.
    Dvornik D
    J Diabetes Complications; 1992; 6(1):25-34. PubMed ID: 1562755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL; Hunsaker LA; Robinson B; Stangebye LA; Deck LM
    J Biol Chem; 1990 Jul; 265(19):10912-8. PubMed ID: 2113526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct stimulation of Na+-K+-ATPase and its glucosylated derivative by aldose reductase inhibitor.
    Garner MH; Spector A
    Diabetes; 1987 Jun; 36(6):716-20. PubMed ID: 3032716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of His-42, His-188 and Lys-263 of human aldose reductase.
    Yamaoka T; Matsuura Y; Yamashita K; Tanimoto T; Nishimura C
    Biochem Biophys Res Commun; 1992 Feb; 183(1):327-33. PubMed ID: 1543503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
    Kato K; Nakayama K; Mizota M; Miwa I; Okuda J
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1540-5. PubMed ID: 1934175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of 7 agents on bovine testis aldose reductase].
    Liu C; Zhu X
    Zhongguo Zhong Yao Za Zhi; 1997 Jun; 22(6):372-3, inside back cover. PubMed ID: 11038893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.